Desk›Healthcare› Indegene Ltd
Indegene Ltd
BSE 544172 · NSE INDGN · ISIN INE065X01017 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology
₹578.65
+2.01%
BSE close, 28 August 2026
₹13,943.54 cr
24.1 cr shares · Small cap
₹5,935.35 cr
as published
61.5× · 7.86×
EPS ₹9.41 · BV ₹73.62
1,220.60 / 211.90
₹ cr, as filed
29
9 selected · 31%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -3.0% |
|---|---|
| Against 52-week low | +39.5% |
| Day change | +2.01% |
| Size band | Small cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹9.41 |
|---|---|
| Price / earnings | 61.49× |
| Price / book | 7.86× |
| Book value — derived, price ÷ P/B | ₹73.62 |
| Return on equity | 12.78% |
| Operating margin | 27.62% |
| Net margin | 17.58% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 12.78%
- ROE as published
- 12.78%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 340.70 | 59.90 | 2.49 | 27.62% | 17.58% |
| Mar-26 · Q | 368.20 | 72.10 | 3.00 | 29.66% | 19.58% |
| FY25-26 | 1,220.60 | 211.90 | 8.83 | 26.74% | 17.36% |
Quarter on quarter
- Revenue, quarter on quarter
- -7.5%
- Net profit, quarter on quarter
- -16.9%
- Operating margin, quarter on quarter
- -204 bps
Disclosure profile 29 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 3 |
| Board Outcome | 1 |
| Change in Directorate | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Restructuring | 1 |
| Results | 1 |
| Selected sub-total | 9 |
| Procedural | |
| Analyst / Investor Meet | 7 |
| AGM / EGM | 3 |
| ESOP Allotment | 2 |
| General | 2 |
| SAST | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Monitoring Agency | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 29 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
29 filings · 9 selected · busiest 2026-07-30
Filing rhythm · the twelve most recent
2026-08-192026-10-08
SelectedProcedural
Filings
29 in the window · 13 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI DP Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
8 October 2026 ·
Allotment of ESOP / ESPS
Allotment of ESOP shares
Company Update / Allotment of ESOP / ESPS View filing →
-
6 October 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
30 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Indegene Limited Q2 FY27 Earnings Call
Company Update / Analyst / Investor Meet View filing →
-
30 September 2026 ·
Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026 Along With The Limited Review Report Of The Auditors Thereon.
Indegene Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated ....
Board Meeting / Board Meeting View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
10 September 2026 ·
Restructuring
Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015 - Merger of Indirect Wholly owned subsidiaries of the Company in Germany
Company Update / Restructuring View filing →
-
8 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investors / Analysts Meeting
Company Update / Analyst / Investor Meet View filing →
-
31 August 2026 ·
Update On Material Litigation
Update on Material Litigation under the Telephone Consumer Protection Act, 1991 involving Wholly- Owned Subsidiary, Indegene, Inc.
Company Update / General View filing →
-
19 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investors / Analysts Meeting
Company Update / Analyst / Investor Meet View filing →
-
19 August 2026 ·
Update On Material Litigation
Update on Material Litigation under the Telephone Consumer Protection Act, 1991 involving Wholly-Owned Subsidiary, Indegene, Inc.
Company Update / General View filing →
-
17 August 2026 ·
Transcript Of The 28Th Annual General Meeting Held On August 13, 2026
Transcript of the 28th Annual General Meeting held on August 13, 2026
AGM/EGM / AGM View filing →
-
17 August 2026 ·
Change in Directorate
Appointment of Ms. Jill Mary De Simone (DIN: 11483134) as an independent Director of the Company
Company Update / Change in Directorate View filing →
-
17 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report - 28th Annual General Meeting
AGM/EGM / AGM View filing →
-
14 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investors / Analysts Meeting
Company Update / Analyst / Investor Meet View filing →
-
13 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 28th Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
12 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investors / Analysts Meeting
Company Update / Analyst / Investor Meet View filing →
-
12 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investors / Analysts Meeting
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BPC Genesis Fund I- A SPV Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
10 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BPC Genesis Fund I SPV Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
6 August 2026 ·
Earnings Call Transcript
Transcript of earnings conference call on financial results for the quarter ended June 30, 2026
Company Update / Earnings Call Transcript View filing →
-
31 July 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of the Q1 FY27 Earnings Call
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Investor Presentation
Analyst Presentation and fact sheet - financial results for the quarter ended June 30, 2026
Company Update / Investor Presentation View filing →
-
30 July 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
30 July 2026 ·
Monitoring Agency Report
Monitoring Agency Report
Company Update / Monitoring Agency Report View filing →
-
30 July 2026 ·
Allotment of ESOP / ESPS
Allotment of Shares under ESOP Scheme 2020
Company Update / Allotment of ESOP / ESPS View filing →
-
30 July 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026
Unaudited Financial Results for the Quarter ended June 30, 2026
Result / Financial Results View filing →
-
30 July 2026 ·
Board Meeting Outcome for For The Meeting Of Board Of Directors Held On 30Th July, 2026
Outcome of the Board Meeting held on 30th July, 2026
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Indegene Ltd · the 50 most recent filings